Terpentecin at a concentration of 0,78^g/ml decreased the number of viable cells of Escherichia coli NIHJ to less than one thousandth the starting number in an hour when added to an exponentially growing culture in a nutrient broth. During this time, the turbidity of the cell suspension kept increasing as fast as the control. Microscopic inspection of the cells exposed to terpentecin under these conditions revealed that the cells were elongated. Terpentecin at a concentration of 6.25^g/ml inhibited incorporation of ponents. Terpentecin at a higher concentration (70 /*g/ml) inhibited by 40% in 30 minutes the incorporation of [me^/-3H]thymidine triphosphate into the DNAfraction of toluenetreated cells of E. coli JE6296 (pol A~). Terpentecin showed stronger antibacterial activities against Bacillus subtilis M45T(rar) and E. coli BE1121(rec A~) than against their corresponding wild type strains. However, terpentecin showed no mutagenicity by the Amestest with Salmonella typhimurium strains TA100, TA98, TA92, TA1538, TA1537 and TA1535, and with E. coli WP2 (uvr A).
Terpentecin at a lower concentration (0.07^g/ml) inhibited growth in vitro of mouse leukemia L1210 cells by 50%. With the mammalian cells again the incorporation of [14C]-thymidine into the acid-insoluble cell material was inhibited more strongly than incorporation of [14C]uridine and [14C]leucine. There was no sign of mutagenicity by the micronucleus test using mice.
Terpentecin is a new antitumor antibiotic produced by Kitasatosporia griseola MF730-N6, a rare actinomycete,^and belongs to the diterpenoid group with the clerodane type of structure2* (Fig. 1 ).
It is active against various Gram-positive and Gram-negative bacteria and shows some antitumor activity, prolonging the life span of mice inoculated with either L1210, P388 or Ehrlich ascites carcinoma. There are few terpenoid antibiotics of actinomycete origin and terpentecin is most closely related in structure and in activities to clerocidin,3'4) a product of a fungus Oidiodendron truncation.
The mechanism of Escherichia coli NIHJ, E. coli BEMll (tol C, F~, thr, leu, pro, his, thi, arg, lac, gal, am, xyl, mtl, tsx, str, sup) , E. coli BE1121 (rec A(l), his+, otherwise the same as BEMll), E. coli JE6269 (pol Al, pur E, trp, lys, pro C, leu, thi, lac Z, xyl, ara, ton A, tsx, str, sup), Bacillus subtilis M45T (rec~, arg~, try+) and B. subtilis H17A (rec+, arg+, try') were used. For the Ames test, Salmonella typhimurium TA100 {his G, rfa, Juvr B, +R), TA98 (his D, otherwise the same as TA100), TA92 (his G, +R), TA1538 (his D, rfa, Juvr B), TA1537 (his C, otherwise the same as TA1538) and TA1535 (his G, otherwise the same as TA1538) and E. coli WP2(uvr A, trp~) were used.
Determination of Inhibition by Terpentecin of Cell Growth E. coli NIHJ was shake-cultured at 37°C in nutrient broth. Cell growth was followed by reading the turbidity (A660nm) of the cultures. At a growth stage of A660nm 0.1f, terpentecin (dissolved in DMSO) was added to give required concentrations and A660nmof the cultures was followed with time.
Determination of Effect of Terpentecin on Cell-viability (Colony-forming Ability) E. coli NIHJ was grown as above. At a growth stage of A660nm0.1, a 4.75-ml portion was transferred into an L-shaped culture tube, mixed with 0.25 ml of terpentecin solution (a desired concentration of terpentecin in 5 % DMSO), and incubated further for 3 hours. During this time, 0.2 ml samples were withdrawn at 30 minute intervals; 0.1 ml portions of a 10-fold dilution series in water prepared from each sample were spread on nutrient agar plates, incubated at 37°C for 18 hours and the number of colonies was counted.
Inspection of Cell Morphology of E. coli NIHJ From a culture of E. coli NIHJ (A660nm 0.1), a 990-/4 portion was transferred into a small test tube, mixed with 10^1 of a terpentecin solution (prepared by dissolving 0.25 jug terpentecin in 5% DMSO;for the control, 10 [A of 5 % DMSOwas used) and incubated further at 37°C for 2 hours with shaking. Asample of the cell suspension was smeared on a slide glass, dried, fixed over a flame, stained with gentian violet solution and submitted to microscopic inspection.
Incorporation of Labeled Precursors into Acid-insoluble Cell Material of E. coli NIHJ
The procedures were as reported.5) E. coli NIHJ was grown in an L-shaped tube with shaking in a nutrient broth which consisted of 1 %(w/y) Polypepton (Daigo-Eiyo Co.), meat extract (Kyokuto Opencircles represent the culture which received no terpentecin (control) while solid symbols represent the ones which received terpentecin at 0.1 jug/m\ (®), 0.2^g/ml (a) and 0.78^g/ml (a).
(b) Effect on cell viability (colony-forming ability). Open circles represent the culture which received no terpentecin (control) while solid symbols represent the ones which received terpentecin at 0.1 /Mg/ml (à") and 0.78^g/ml (a). or absence of terpentecin. Negligible inhibition of this process was observed (data not shown). We next divided the total intracellular radioactivity into acid-soluble and acid-insoluble fractions to know whether the blockade was at the polymerization step or somewherebefore. As shown in Table 1 , the radioactivity in the acid-soluble fraction from terpentecin-treated cells was rather larger than that from control cells (1,524 vs. 1,347 dpm). In marked contrast were the reverse results with the acidinsoluble fractions (2,376 vs. 8,465 dpm). These strongly suggest that terpentecin inhibits the polymerization step. ATP-dependent DNAsynthesis in toluene-treated cells with 4 dXTP's as the sub-strates is believed to represent replicative DNAsynthesis in cells.8) Terpentecin inhibited this process (Table 2) , either with E. coli JE6269 (DNA-repair defective) or with E. coli NIHJ, although at higher concentrations of the antibiotic than required for inhibition of DNAsynthesis in living cells (Fig. 4 and Table 1 ).
The difference in sensitivity to terpentecin between DNAsynthesis in living cells and in toluenetreated cells could be caused by metabolic conversion of terpentecin to a stronger inhibitor of DNA synthesis in living cells. Howdoes terpentecin (or its metabolites) inhibit DNAsynthesis? Covalent modification of DNA,such as strand scission, adduct formation, etc, are the most likely mechanisms explaining both bactericidal effects and inhibition of DNAsynthesis. Antibiotics with these activities generally show stronger antibacterial activities against bacterial strains defective in DNA recombination and/or DNArepair than against proficient strains.10'11* Antibacterial activities of terpentecin against rec+ and rec~strains were compared by the agar dilution method of Yoshimoto et al.12) using B. subtilis M45T(rec~) and H17A (rec+) and E. coli BE1121 (rec) and BEMll (rec+).
In both cases, the rec~strains [3H]Thymidine, when added instead of [3H]dTTP, was poorly incorporated under these conditions indicating the effectiveness of the toluene treatment.
NT: Not tested.
were over 8 times more sensitive to terpentecin than were the corresponding rec+ strains. Possible DNAlesion(s) induced by terpentecin should be repaired at least in part by a recombination mechanism. An interesting finding in this connection was that terpentecin has no mutagenecity, either with strains of S. typhimurium sensitive to point mutations (TA100, TA1535)or with ones sensitive to frame-shift mutations (TA98, TA1537, TA1538) in the presence or absence of S9-mixture. Characterization of DNAlesion(s) requires additional studies. Attempts were made to determine direct effect of terpentecin on isolated DNA,if any; these include possible alteration of Tm and/or of the UVabsorption profile of DNA,possible strand scission of DNA,and possible effects on characteristic cleavages of DNAwith some restriction endonucleases. None was positive, however (data not shown). It is unlikely that the target of terpentecin is DNApolymerase or some other proteins important for DNAsynthesis because of the following reason. Inactivation of such proteins, even though irreversible, does not explain the bactericidal effect of terpentecin which was revealed by the colony counting method (Fig. 2b) . In this method, the cell suspensions including terpentecin were greatly diluted and plated on the agar mediumto allow viable cells to form colonies. The logic is that once the concentrations of terpentecin are greatly reduced, the newly synthesized proteins (DNApolymerase or others) can replace the inactivated proteins and support synthesis of DNAand in turn the cells can start growing to form colonies.
Terpentecin was originally isolated because of its effectiveness in elongating the life span in tumorinoculated mice. Terpentecin at 0.07 /<g/ml inhibited growth in vitro of mouse leukemia L1210 cells by 50%in 2 days. With the mammalian cells as with E. coli, incorporation of [14C]thymidine in 60 minutes was inhibited more strongly by terpentecin (1.6 fig/ml) than was the incorporation of [14C]-uridine or [14C]leucine; IC40%t values for incorporation of thymidine, uridine and leucine into cultured LI210 leukemia cells were 1.6, 7.2 and 28 A*g/ml, respectively. The target of terpentecin, therefore, seems to be a structure, most likely the DNAtemplate, which is commonto bacterial and mammalian cells. Possible mutagenicity to mammaliancells was also determined by the micronucleus test.13) Terpentecin dissolved in 5 % dimethyl sulfoxide solution was injected intraperitoneally into 7-weekold male ICR mice and 24 hours later marrowspecimens were taken from femurs and the number of cells with micronuclei among1,000 polychromatic erythrocytes of each specimen was counted. The marrow specimens taken from the mice treated with 25 mg/kg and 50 mg/kg terpentecin showed 4 and 6 cells, respectively, with micronuclei as opposed to 3 in the control and 63 in the specimen derived from a mousetreated with 2 mg/kg mitomycinC. Thushere again little or no mutagenicity was apparent. The lack of mutagenicity should be advantageous if terpentecin is used as an antitumor agent.
